The severity of symptoms varies from one person to another and depends on two factors: how much or little enzymes a person produces; and on the quantity of food consumed.
The easiest test for a food intolerance is to remove the food from your diet for at least two weeks, see if symptoms improve and then try reintroducing the food (one by one). If symptoms return, an intolerance is likely.
Lactose intolerance can be tested far more thoroughly using a lactose tolerance test, a hydrogen breath test and a stool acidity test. Your doctor can arrange these and other food intolerance tests if necessary.
Food intolerance can be managed simply by cutting the food out of your diet. Babies or younger children with a lactose intolerance can be given soya milk instead of cow's milk. Adults may be able to tolerate small amounts of troublesome foods, so may need to experiment to work out what they can eat.
Supplements of digestive enzymes make life easier. The right enzyme will help break down food consumed that before it caused the symptoms. These enzymes are now available from foodreactions.org. Below is a list of digestive enzymes to help you understand which enzyme is required to break which food.
An enzyme is a protein that binds itself to a substance and converts it into another substance or smaller substances. Unless proteins, fats and carbohydrates (sugars) are converted into absorbable components they will remain in the digestive track leading to unpleasant symptoms as a result of their consumption by the bacteria living in our guts. The following table gives a glance for what each enzyme does and where it is produced/found:
Opiate withdrawal refers to a wide range of symptoms that can occur once opioid intake is interrupted or reduced. The amount, length and intensity of the symptoms vary from person to person. For some individuals, it can be a natural process, and for others, withdrawal can be severe. Opiate withdrawal occurs because it takes time for the body to regulate to no longer having the drug in the system.
An opioid is synthetic narcotic works similarly to naturally occurring opiates. These opiate-like substances bind to the opioid receptor sites in the brain, spinal cord, and gastrointestinal tract. Once the drugs attach to these receptor sites, they immediately exert their effects. The brain manufactures its own opioids which are responsible for a host of physical responses. Some of these reactions are the decrease of pain, a slower respiratory rate, and sometimes even used to control anxiety or depression. However, the body does not produce the number of opioids needed to manage high levels of pain. Taking prescription or illicit opioids can reduce adverse effects caused by pain, but with an array of dangerous side-effects.
Opiate withdrawal symptoms can be harsh to surpass if not correctly treated. The fear of going through withdrawal is what keeps many people dependent upon drugs like Heroin and Oxycodone. They don’t want to stop using opiates because they fear a return of pain and withdrawal symptoms that can resemble the worst imaginable flu. Symptoms can affect the individual both physically and emotionally.
An important fact to keep in mind is that different opioids remain in your system for various lengths of time what can affect the withdrawal syndrome onset. The amount of time your symptoms last depends on a combination of factors including frequency and amount of the use, length of the addiction, as well as individual factors like your health and emotional status.
Opiate withdrawal symptoms can include
- Strong cravings
- Muscle aches
- A runny nose
- Dilated pupils.
In most cases, these symptoms can be managed by a specialized medical treatment facility Opiate withdrawal can be a long and painful process and very hard to get through. For health compromised patients, untreated and unmonitored withdrawal can lead to unnecessary medical complications such as nausea, rapid heart-rate, elevated blood pressure and dehydration. The consecutive loss of fluids & electrolytes can cause abnormal heart rate and low potassium levels, which can lead to blood circulation issues or even a heart attack.
A medically supervised opiate withdrawal in a controlled environment can make the withdrawal much safer and more comfortable. It also provides a much a higher chance of success. In the past, opiate-dependent patients had no choice but to undergo conventional detoxification procedures in nonmedical facilities such as a drug rehab; It caused them to suffer through an unnecessary debilitating and sometimes even dangerous withdrawal syndrome.
For more information on Medical Opiate Withdrawal Treatment, Call Today 1-800-423-2482
Natural opiates are alkaloids found in the opium poppy plant, and examples are morphine, codeine, and thebaine. Semi-synthetic opioids are created from natural opiates and include oxycodone, hydrocodone, and hydromorphone. Fully synthetic opioids include fentanyl, methadone, and tramadol.
People who use opiates for the medical condition can also become physically dependent and require a medical opiate detox. One can take these medications safely over a relatively short period. However, most people become dependent when long-term therapy is needed. This is what makes pain management so tricky. Opiates are prized for their ability to defeat pain. Unfortunately, tolerance, dependence, and addiction can set in, even when the drugs are used correctly. Once this happens, the body needs more of the drug to experience the same effect. This increases the risk of a drug overdose.
Drug overdose is the leading cause of death in the United States. The American Society of Addiction Medicine (ASAM) reports that 100 people die of a drug overdose daily, and 46 people are due to prescription opioid overdose.
Many opioid withdrawal treatment programs, often rely on “replacement” or “substitution” medications such as methadone, Suboxone ( Buprenorphine) or Subutex. These medications are also opioids and may prolong the length of the opiate addiction. Eventually, people dependent on these drugs will require detoxification. For some, Medication-Assisted Therapy (MAT) might be safer than street drugs; for others, being completely opioid-free is the best option. Choosing the appropriate medical detox or the best rapid detox center can dictate the quality and efficiency of the opiate withdrawal treatment.
The Waismann Method ® of rapid detoxification has demonstrated tremendous success in getting patients comfortably and safely through opiate withdrawal. Recognized as the best opiate treatment center in the world, by offering exceptional medical care and individualized assessment.
If you or a loved one is planning to stop taking opiates and have a fear of the withdrawal symptoms side effects, gives us a call today at 310-205-0808. Let us tell you how we can help manage your symptoms and get you through this challenging phase privately and compassionately.
Seeking medical help for an opiate addiction will improve your quality of life, your overall health, reduce the risk of accidental overdose and other related complications. Don’t wait another day, seek help now!
peste clasica, swine fever, varkenspest, peste porcine, Schweinepest, hog cholera
PDNS confused with CSF: details
OIE: Diagnosis Spread Survival of classical swine fever virus: factsheet
Results from a retrospective nursing home study in the United States show influenza has been found to negatively affect functional status in seniors significantly, and has been associated with activities of daily living (ADL) decline. 11*
* FLUZONE ® High-Dose is not indicated for the prevention of mortality or hospitalization or complications associated with influenza, such as activities of daily living decline (ADL), independence, quality of life or influenza-attributed morbidity and mortality associated with stroke, heart attack, kidney disease and diabetes.
of flu-related hospitalizations 2
of flu-related deaths 2
Canada's National Advisory Committee on Immunization (NACI) considers adults over the age of 65 to be at high risk of influenza-related complications or hospitalization and recommends that all seniors get an influenza vaccine annually. 3
FLUZONE ® High-Dose influenza vaccine has been shown to be more effective for seniors than FLUZONE ®† , our standard dose influenza vaccine. 12
FLUZONE ® High-Dose has been shown to have superior efficacy in preventing laboratory-confirmed influenza compared to the FLUZONE ® standard dose vaccine †. In a large multi-centred clinical trial (conducted in US and Canada) FLUZONE ® High-Dose demonstrated a superior relative efficacy of 24.2% (95% CI: 9.7 - 36.5) in preventing influenza illness attributed to any viral type or subtype. The attack rates of laboratory-confirmed influenza-like illness (primary endpoints) were 1.43% in the FLUZONE ® High-Dose arm and 1.89% for the FLUZONE ®† arm. 1 **
Though it has only been available in Canada since 2015, FLUZONE ® High-Dose is not new. It has been available in the US since 2009, with over 90 million doses distributed to date. 13
In choosing a vaccine product, it is important to consider the relative burden of influenza disease caused by the various influenza subtypes (i.e., influenza A(H1N1), influenza A(H3N2) and influenza B) in this age group, as well as the efficacy, immunogenicity and safety profile of the available vaccines. 3
† Fluzone trivalent standard-dose vaccine is not marketed/available in Canada.
** The pre-specified statistical superiority criterion for the primary endpoint (lower limit of the 2-sided 95% CI of the vaccine efficacy of FLUZONE ® High-Dose relative to FLUZONE ® >9.1%; p-value against H0: VE ® High-Dose or FLUZONE ® Trivalent. The study was conducted over two influenza seasons (2011-2012 and 2012-2013). FLUZONE ® High-Dose contained 60 μg of HA per strain while FLUZONE ® Trivalent contained 15 μg of HA per strain. The per-protocol analysis set for efficacy assessments included 15,892 FLUZONE ® High-Dose recipients and 15,911 FLUZONE ® Trivalent recipients. The primary endpoint of the study was the occurrence of laboratory-confirmed influenza, defined as a new onset (or exacerbation) of at least one of the following respiratory symptoms: sore throat, cough, sputum production, wheezing, or difficulty breathing; concurrent with at least one of the following systemic signs or symptoms: temperature > 37.2°C, chills, tiredness, headaches or myalgia.
In the first year of the study, the influenza B component of the vaccine and the majority of influenza B cases were of the Victoria lineage; in the second year, the influenza B component of the vaccine and the majority of influenza B cases were of the Yamagata lineage.
Contact your Provincial Public Health Unit today to see if FLUZONE ® High-Dose is covered for your 65+ patients.
- Publicly funded for personal care homes in Manitoba for 65+ 14
FLUZONE ® High-Dose is indicated for active immunization against influenza caused by the specific strains of influenza virus contained in the vaccine in adults 65 years of age and older. Annual vaccination against influenza using the current vaccine is recommended as immunity declines in the year following vaccination. i
- Should not be administered to anyone with a history of severe allergic reaction to egg protein or any component of the vaccine or after previous administration of FLUZONE ® High-Dose or a vaccine containing the same components or constituents. ii
- FLUZONE ® High-Dose is not indicated for persons less than 65 years of age. iii
- As with any vaccine, immunization with FLUZONE ® High-Dose may not protect 100% of individuals. Protection is limited to those strains of virus from which the vaccine is prepared or against closely related strains. iv
- Do not administer FLUZONE ® High-Dose by intravascular injection. Do not administer into the buttocks. v
- Postpone vaccination in case of moderate/severe febrile illness or acute disease. vi
- Administer FLUZONE ® High-Dose with caution in persons suffering from coagulation disorders or on anticoagulation therapy. vii
- Immunocompromised persons (whether from disease or treatment) may not elicit the expected immune response. viii
- Avoid vaccinating persons who are known to have experienced Guillain-Barré syndrome (GBS) within 6 weeks after a previous influenza vaccination. ix
Consult the product monograph at www.sanofipasteur.ca/node/17902 for important information relating to adverse reactions, drug interactions, and dosing information which have not been discussed in this piece. The product monograph is also available through our medical department. Call us at 1-888-621-1146.
1. Sanofi Pasteur Limited. FLUZONE ® High-Dose Influenza Virus Vaccine Trivalent Types A and B (Split Virion). Product Monograph. Date of Approval: May 2017. 2. Public Health Agency of Canada (PHAC). FluWatch. May 3 to May 9, 2015. 3. Public Health Agency of Canada (2016). An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017-2018. 4. Health Indicator Profile Statistics Canada. (2014). Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2013 boundaries) and peer groups, *Archived*. Table 105-0501. Retrieved June 12, 2017 from Statistics Canada: http://www.statcan.gc.ca/pub/82-624-x/2015001/article/14218-eng.htm. 5. Statistics Canada. (2013) Population Projections for Canada (2013 to 2063), Provinces and Territories (2013 to 2038): Section 2 – Results at the Canada level, 2013 to 2063. (Catalogue number 91-520-X). Retrieved June 12, 2017 from Statistics Canada: http://www.statcan.gc.ca/pub/91-520-x/2014001/section02-eng.htm. 6. Grau AJ, et al. Influenza Vaccination Is Associated With a Reduced Risk of Stroke. Stroke. 2005; 36(7):1501-1506. 7. Udell JA. et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711-1720. 8. Centers for Disease Control and Prevention (CDC). Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season. MMWR Recommendations and Reports Vol. 65 No. 5. August 26, 2016. 9. Husein N, et al. Influenza and Pneumococcal Immunization Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Journal of Diabetes. 2013;37 Supplement 93. 10. Chen C-I, et al. Influenza Vaccination is Associated with Lower Risk of Acute Coronary Syndrome in Elderly Patients with Chronic Kidney Disease. Medicine (Baltimore). 2016;95(5). 11. Gozalo PL, et al. The impact of influenza on functional decline. Am Geriatr Soc. 2012;60(7): 1260–1267. 12. DiazGranados, C.A., et al. (2014). Efficacy of High-Dose versus Standard-Dose influenza Vaccine. New England Journal of Medicine, 371, 635-645 13. Sanofi Pasteur Inc. Data on file. Distribution Letter Fluzone® High-Dose Influenza Vaccine - Doses Distributed. November 16, 2017. 14. Government of Manitoba (2017). Manitoba First in Canada to introduce New Flu Vaccine for Personal Care Home Residents http://news.gov.mb.ca/news/index.html?item=42125&posted=2017-09-05. September 5, 2017.
FLUZONE ® is a trademark of Sanofi Pasteur. Sanofi Pasteur 1755 Steeles Avenue West, Toronto, Ontario M2R 3T4
© 2017 Sanofi Pasteur Limited. All rights reserved. DIN: 02445646 SPCA.FLHD.17.08.0044 E
I FLUZONE ® High-Dose Influenza Virus Vaccine Trivalent Types A and B (Split Virion).
Product Monograph. Date of Approval: May 2017.
Un vaccin à haute dose contre l’influenza conçu spécifiquement pour les personnes de 65 ans et plus 1
Les adultes de 65 ans et plus souffrent de manière disproportionnée de morbidité et de mortalité associées à l’influenza 2,3. L’immunité diminue avec l’âge 1 . Bien que les personnes âgées affichent le plus haut taux d’immunisation contre l’influenza de tous les groupes d’âge (plus de 60 %) 4, les vaccins sont environ à moitié moins efficaces chez les personnes âgées que chez les adultes en santé, et leur efficacité varie selon les critères d’évaluation et la population à l’étude 3.
New hope for better flu vaccines 1
Halton Region reports 2 flu-related deaths this season:Georgetown. 1
Germany's CureVac wins new vaccine funding from Gates Foundation 1
Flu kills child in Guelph, second child's death may also be from flu 1
Can Telehealth or access to a doctor online keep you safe? 1
Numbness after flu shot 1
Winter, flu season affecting blood collection 5
Twin Boys age 4 one has the flu 1
Oklahoma flu deaths rise to 74 this season 1
Dog flu is real: Here's what you need to know to keep your pet safe 1
How one Toronto hospital is coming back to life to bring relief to five more 1
Got the flu? Here's what leads to recovery 1
worried about wife's flu 1
First-time suffering from the flu can I have some info please 1
The flu shot is largely worthless and possibly dangerous 1
Acute leukemia may cause signs and symptoms that are similar to the flu. They come on suddenly within days or weeks.
Chronic leukemia often causes only a few symptoms or none at all. Signs and symptoms usually develop gradually. People with a chronic leukemia often complain that they just do not feel well. The disease is often found during a routine blood test.
Other health conditions can cause the same symptoms as leukemia. See your doctor if you have:
- a general feeling of discomfort or illness (called malaise)
- loss of appetite
- weight loss
- shortness of breath
- rapid heartbeat (called palpitations)
- easy bruising
- frequent or severe nose bleeds
- bleeding gums
- bleeding in the middle of a menstrual cycle or heavy menstrual flow
- tiny, flat, red spots caused by bleeding just under the surface of the skin (called petechiae)
- frequent infections in the lungs, urinary tract or gums or around the anus
- frequent cold sores
- sore throat
- night sweats
- bone or joint pain
- enlarged lymph nodes in the neck, underarm, groin or above the collarbone
- abdominal discomfort or feeling of fullness
- vision problems
- sores in the eyes
- swelling of the testicles
- chloroma – a collection of leukemia cells, or blasts, under the skin or in other parts of the body
- leukemia cutis – appears as sores or as patches of any size that are usually pink or tan in colour
- leukocytoclastic vasculitis – a condition that looks like an allergic reaction on the skin and usually causes sores on the hands and feet
- Sweet’s syndrome, or acute febrile neutrophilic dermatosis – causes fever and painful sores that may appear anywhere on the body
In some cases, leukemia or its treatments can cause serious problems. These cancer-related emergencies need to be treated right away.
Tumour lysis syndrome can occur when chemotherapy is given to treat acute leukemia, but the cancer cells die quickly and the kidneys can’t remove the substances they release from the blood fast enough. Find out more about tumour lysis syndrome.
Superior vena cava syndrome (SVCS) may occur when too many leukemia cells develop in the thymus, causing it to get bigger and block the windpipe. SVCS may develop with acute lymphocytic leukemia (ALL). Find out more about superior vena cava syndrome.
Disseminated intravascular coagulation (DIC) is a condition where blood clots develop in the bloodstream and bleeding also occurs. DIC can develop more often with acute promyelocytic leukemia, but also with other subtypes of acute myelogenous leukemia (AML). Find out more about disseminated intravascular coagulation.
A rare, cancerous (malignant), green-coloured tumour that develops with myelogenous leukemia. It is formed by the buildup of abnormal blast cells (immature blood cells) that collect in soft tissue outside the bone marrow.
Chloromas develop most often in the bone, skin, lymph nodes, breast, ovary, meninges (membranes that cover and protect the brain or the spinal cord) and around the eye.
Also called extramedullary leukemia or granulocytic sarcoma.
Milk allergy is caused when the immune system (IS), which is there to protect us from bacteria and infections, mistakenly marks one or more of the 25 proteins found in milk to be harmful. Therefore it initiates a response to fight against the milk protein/s. The IS through specialised cells releases toxins, and it is these toxins that make persons with milk allergy to suffer the symptoms associated with food allergy. Milk is ranked among the top offenders for food allergies! In fact, many doctors, scientists, and health specialists recommend going dairy free as an initial test when a food allergy is suspected.
The symptoms of a milk protein allergy fall into 3 types of reactions:
- Hives - red, itchy bumps on skin
- Oedema - swelling of the skin, sometimes of the eyes and lips
- Eczema - a dry and bumpy rash
Stomach and Intestinal Reactions:
- Abdominal pain and bloating
- Diarrhoea (usually very runny)
Nose, Throat and Lung Reactions:
- Runny Nose
- Watery and/or Itchy eyes
- Shortness of Breath
Milk allergy is often muddled with lactose intolerance. It is very important to understand the differences because it is only this way that you can help avoid the symptoms. When a person reacts to milk, the first assumption is that it is an allergy. However, things are the opposite, because while only around 2% of adults suffer from milk allergy the amount of people who have lactose intolerance are 50% or more! Lactose intolerance is caused by insufficient amount of enzymes to break down lactose, the sugar found in milk. For more details on lactose intolerance read here.
The table below shows the differences between lactose intolerance and milk allergy. Some symptoms may be common for both.